OKYO Pharma Limited Income Tax Expense Continuing Operations
OKYO Pharma Limited (OKYO) reported Income Tax Expense Continuing Operations of $3.26 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2025-07-18
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2025-03-31 | $3.26M 20-F · filed 2025-07-18 |
| 2024-03-31 | -$22.42K 20-F · filed 2025-07-18 |
| 2023-03-31 | $12.20K 20-F · filed 2025-07-18 |
| 2022-03-31 | $786.52K 20-F · filed 2024-08-13 |
| 2021-03-31 | $24.99K 20-F · filed 2023-08-15 |
| 2020-03-31 | $76.29K 20-F · filed 2022-08-15 |